Concepedia

Author

Craig R. Nichols

Indiana University – Purdue University IndianapolisORCID

Also Known As

C Nichols, C R Nichols, C. Nichols, C. R. NICHOLS, C. R. Nichols, C.R Nichols, C.R. Nichols, CRAIG R. NICHOLS, Casey D Nichols, Craig Nichols

242

Publications

11.5K

Citations

59

H-Index

98

Concepts

All Affiliations

Indiana University – Purdue University IndianapolisOregon Health & Science UniversityIndiana University School of MedicinePalmetto Hematology OncologyVirginia Mason Medical Center
CR

About

Craig R. Nichols is an author at Indiana University – Purdue University Indianapolis specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

31

42

3.7K

2

Public Health

10

10

763

3

Health Sciences

2

2

469

4

Natural Sciences

1

1

127

5

Biochemistry

1

1

127

Craig R. Nichols

×

88

Publications

9K

Citations

54

H-Index

YearCitations

Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: Results From an International Analysis

Carsten Bokemeyer, Craig R. Nichols, J P Droz,

Journal of Clinical Oncology

2002

497

Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor.

Patrick J. Loehrer, R Gonin, Craig R. Nichols,

Journal of Clinical Oncology

1998

399

Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.

Craig R. Nichols, Guido Tricot, Stephen D. Williams,

Journal of Clinical Oncology

1989

351

Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study.

Craig R. Nichols, Paul J. Catalano, Emily Crawford,

Journal of Clinical Oncology

1998

342

Patterns of Relapse in Patients With Clinical Stage I Testicular Cancer Managed With Active Surveillance

Christian Kollmannsberger, Torgrim Tandstad, Philippe L. Bédard,

Journal of Clinical Oncology

2014

342

High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.

J. Beyer, A. Kramar, Romeo A. Mandanas,

Journal of Clinical Oncology

1996

319

Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2

D. L. Barton, H. Liu, S. R. Dakhil,

JNCI Journal of the National Cancer Institute

2013

294

Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.

Craig R. Nichols, Stephen D. Williams, Patrick J. Loehrer,

Journal of Clinical Oncology

1991

288

Viable Malignant Cells After Primary Chemotherapy for Disseminated Nonseminomatous Germ Cell Tumors: Prognostic Factors and Role of Postsurgery Chemotherapy—Results From an International Study Group

Karim Fizazi, Sergei Tjulandin, Roberto Salvioni,

Journal of Clinical Oncology

2001

279

Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: Clinical and epidemiologic observations

Andrew T. Pavia, Craig R. Nichols, David P. Green,

The Journal of Pediatrics

1990

255

Page 1